Abbott Laboratories (NYSE:ABT) Updates FY23 Earnings Guidance

Abbott Laboratories (NYSE:ABT – Get Rating) issued an update on its FY23 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $4.30-4.50 for the period, compared to the consensus earnings per share estimate of $4.39. Abbott Laboratories Stock Performance Shares of Abbott Laboratories stock opened at $104.15 on Wednesday. The firm […]

Related Keywords

Wisconsin ,United States ,Silverlake ,Juliel Tyler ,Randel William Woodgrift ,Stifel Nicolaus ,Morgan Stanley ,Abbott Laboratories ,Capital Management ,Wisconsin Capital Management ,Fortis Capital Advisors ,Partners Inc ,Silverlake Wealth Management ,Wells Fargo Company ,Securities Exchange Commission ,Get Rating ,Moderate Buy ,William Woodgrift ,Exchange Commission ,Finance Capital Management ,Wealth Management ,Established Pharmaceutical Products ,Diagnostic Products ,Nutritional Products ,Abbott Laboratories Daily ,Nyse Abt ,Abt ,Medical ,00282410 ,Guidance ,Earnings ,Preannouncement ,